Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 183 of 1,261

  1. US 11702630

    In vitro methods of differentiating stem cells into neurons and neurons generated using the same

    The Regents of the University of California · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  2. US 11702419

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  3. US 11702423

    BRM targeting compounds and associated methods of use

    Prelude Therapeutics, Incorporated · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  4. US 11702453

    Materials and methods for inhibiting flavivirus infection

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  5. US 11696898

    Halogenated ether compounds and methods of inducing anesthesia

    The Regents of the University of California · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted

  6. US 11697669

    Hemi-citrate salts of GABA-A positive allosteric modulator and crystalline form thereof

    PRAXIS PRECISION MEDICINES, INC. · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted

  7. US 11696950

    Dry solid aluminum adjuvant-containing vaccines and related methods thereof

    The Board of Regents of the University of Texas System · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted

  8. US 11696933

    HLA-restricted VCX/Y peptides and T cell receptors and use thereof

    The Board of Regents of the University of Texas System · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted

  9. US 11696922

    Nanoparticle to target cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted

  10. US 11697667

    Salts and polymorphs of cethromycin for the treatment of disease

    AliquantumRx, Inc. · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted

  11. US 11696929

    Methods and systems for conserving highly expanded cells

    The Regents of the University of California · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted

  12. US 11697639

    Quaternary ammonium salt compound, preparation method therefor and use thereof

    WEST CHINA HOSPITAL, SICHUAN UNIVERSITY · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted

  13. US 11696572

    Non-human animals comprising a humanized ASGR1 locus

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted

  14. US 11696903

    Compounds and methods for scavenging dicarbonyl electrophiles

    THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted

  15. US 11696956

    Bicyclic peptide ligands specific for EphA2

    BicycleTx Limited · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted

  16. US 11699503

    Methods of identifying and treating patient populations amenable to cancer immunotherapy

    The Regents of the University of California · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted

  17. US 11697689

    Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic potential of drugs

    INSTITUT DE CANCEROLOGIE DE L'OUEST · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted

  18. US 11697676

    Anti-human papillomavirus 16 E6 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted

  19. US 11696904

    Prodrug for therapeutic applications

    The Regents of the University of California · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted

  20. US 11697648

    Fused pyrimidine pyridinone compounds as JAK inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted

  21. US 11696893

    Preparation comprising vonoprazan

    Takeda Pharmaceutical Company Limited · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted

  22. US 11696896

    Immunomodulatory nanoparticle treatment of brain injury

    Northwestern University · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted

  23. US 11691972

    Compounds for targeted degradation of BRD9

    C4 THERAPEUTICS, INC. · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted

  24. US 11691992

    Oxaborole analogs and uses thereof

    The Government of the United States, as represented by the Secretary of the Army · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.